Dr. Wilson Liao, Chair of the NPF Scientific Advisory Committee, discusses the latest in psoriatic disease research.

This rare type of psoriasis can be difficult to treat and live with, but dermatologists may soon have more effective, targeted therapies.

Newly diagnosed? Want a refresher? Dr. Jason E. Hawkes is here to break down the science of psoriatic disease.

Dr. Alexa B. Kimball has dedicated her career to bettering the psoriasis community through research.

The traditional Western diet alters the gut microbiome, which may influence psoriatic inflammation.

SKYRIZI® (risankizumab-rzaa) is now available in the U.S. as a single dose injection for the treatment of adults with moderate-to-severe plaque psoriasis.

Luke struggled for years to overcome self-esteem issues related to the appearance of his psoriasis.

The 2021 NPF Research Symposium will feature experts in psoriatic disease research.

Commemorating the 5-year anniversary of the psoriasis meeting at the FDA.

You name a treatment, Glenn has probably tried it.

Drexel opens up about self-confidence challenges and navigating the workplace with a chronic disease.

John has been managing life with psoriasis since 1964.

This singer opens up about managing scalp psoriasis and not being ashamed of skin symptoms.

This teenager has been dealing with psoriasis for over 10 years.

The latest NPF podcast breaks down why your gut could be the key to a healthier you.

This Psoriasis Action Month, we meet the people who make our community vibrant and unique.

People living with PsA should be assessed for metabolic syndrome, given the elevated risk for heart disease and other effects.

Join us for the upcoming 2021 Research Symposium – Improving Health Outcomes.

Avid hiker and NPF volunteer Darren Hitz shares his thoughts and tips for those looking to hit the trails this summer.

Tattoos on skin affected by psoriasis come with risks, but that isn’t stopping people from expressing themselves.

Why this unhealthy habit can make your psoriasis worse and harder to treat.

The FDA has approved the use of Cosentyx in patients 6 years old and older who are candidates for systemic therapy or phototherapy.

Understanding the impacts of copay accumulator adjustment programs.